Ranitidine in the treatment of mild to moderate esophageal reflux: A multicenter trial

Current Therapeutic Research

Volumn 53, Issue 5, 1993, Pages 513-520

  Uleri, S ^a   Squassante, L ^a   Castelli, G ^a  

^a GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS;

EID: 0027258052     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(05)80658-7     Document Type: Article

References (10)

1. Pathogenesis of reflux esophagitis. Prostaglandins in the gastrointestinal mucosa: Are they important in disease or treatment?
2. Role of acid and pepsin in acute experimental esophagitis
3. Ranitidine. An update review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases
4. Ranitidine
5. Healing and relapse of reflux esophagitis during treatment with ranitidine
6. Oral cimetidine in reflux esophagitis: A double blind controlled trial
7. The esophagus
8. Effect of three ranitidine dosage regimens in the treatment of reflux oesophagitis: Result of a multicentre trial
9. Acute treatment of reflux oesophagitis: A multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s.
10. Ranitidine for erosive esophagitis: A double-blind, placebo-controlled study